Regenocyte Successfully Treats Cardiomyopathy Patient Using His Own Adult Stem Cells

BONITA SPRINGS, Fla.--(BUSINESS WIRE)--

Les Nachman had been battling severe heart disease for more than 10 years by the time he met Dr. Zannos Grekos, a Florida-based pioneer in the field of adult stem cell therapy which utilizes the patient’s own stem cells to treat heart disease and other disorders. Six months following the procedure, his Ejection Fraction – the rate at which the heart is able to expel blood - has improved a remarkable 18 percentage points.

Nachman’s disease had gotten progressively worse over the 10 years since his initial diagnosis. His Ejection Fraction (EF) was down to 23 percent. A normal EF is above 50 percent; Nachman’s 23 percent was in the severe disfunction range.

Nachman spent years tirelessly pursuing all kinds of remedies for his weakening condition, from traditional medicine to various kinds of alternative treatment. A year ago, his desperate search for improved health led him to Orlando to a regenerative medicine conference.

While there, he happened to hear an inspiring presentation by Dr. Grekos, a world leader in the use of a patient’s own stem cells to treat a variety of conditions and diseases.

In his presentation about Regenocyte's procedure Dr. Grekos described how blood is extracted from the patient and sent on to a laboratory in Israel, where the patient’s stem cells are removed.

“The lab in Israel provides a key step in the Regenocyte process,” Dr. Grekos explained. “The lab extracts the stem cells from the blood and genetically engineers them into millions of adult stem cells while ‘educating’ them to assist the exact organ that needs treatment.”

About a week after the blood arrives in Israel, the adult stem cells are shipped to a hospital in the Dominican Republic. By this time, the patient also has traveled to the Dominican Republic and has been admitted to the same hospital.

In this ground-breaking treatment, Dr. Grekos inserted a catheter into the left ventricle of Nachman’s heart. Over the next 20 minutes, about 30 separate injections of adult stem cells were introduced into a seriously damaged part of Nachman’s heart. The process of tissue repair began almost immediately.

Nachman remained in the hospital overnight for observation, and was discharged the next day. Three months later, his Ejection Fraction was measured again, and doctors found that it had risen from 23 percent to 38 percent – not yet “normal,” but considerably better than the life-threatening levels recorded before the treatment.

At his recent six month Multi Gated Acquisition (MUGA) scan, Nachman's Ejection Fraction registered at an incredible 41 percent.

“A patient’s own stem cells can do remarkable things when it comes to the treatment of serious heart, vascular and other diseases,” Dr. Grekos said. "This treatment is not just giving patients hope, it is giving them back their lives."

Nachman feels much better, and says he expects his Ejection Fraction to rise even more when he is tested again in a few months.

“I’m thinking about dancing again and doing things I haven’t done,” Nachman said. “I stay in the office instead of leaving to take a nap. My life has taken on a whole new meaning, and I have a good feeling about this lasting.”

Dr. Grekos periodically conducts seminars to educate the public about adult stem cell therapy. The next two seminars will be Feb. 8 and 24 at 1 p.m. at the Collier County Regional Library, 2385 Orange Blossom Drive, Naples, Fla. To register, call 1-866-216-5710 or visit www.regenocyte.com .

ABOUT REGENOCYTE THERAPEUTIC

Working in collaboration with major international treatment and research centers, Dr. Zannos Grekos has developed many of the protocols used for adult stem cell therapy throughout the world. He has been appointed to the Science Advisory Board of the United States’ Repair Stem Cell Institute and is a member of the International Society for Stem Cell Research (ISSCR). Regenocyte Therapeutic treats congestive heart failure, cardiomyopathy, peripheral artery disease, coronary artery disease, ischemic heart disease and pulmonary disease. For more information, visit www.regenocyte.com .